25-Hydroxyvitamin D levels and cognitive performance and decline in elderly men - PubMed (original) (raw)

Multicenter Study

. 2010 Jan 5;74(1):33-41.

doi: 10.1212/WNL.0b013e3181c7197b. Epub 2009 Nov 25.

M L Paudel, B C Taylor, H A Fink, A Ishani, M T Canales, K Yaffe, E Barrett-Connor, E S Orwoll, J M Shikany, E S Leblanc, J A Cauley, K E Ensrud; Osteoporotic Fractures in Men (MrOS) Study Research Group

Collaborators, Affiliations

Multicenter Study

25-Hydroxyvitamin D levels and cognitive performance and decline in elderly men

Y Slinin et al. Neurology. 2010.

Abstract

Objective: To test the hypothesis that lower 25-hydroxyvitamin D [25(OH)D] levels are associated with a greater likelihood of cognitive impairment and risk of cognitive decline.

Methods: We measured 25(OH)D and assessed cognitive function using the Modified Mini-Mental State Examination (3MS) and Trail Making Test Part B (Trails B) in a cohort of 1,604 men enrolled in the Osteoporotic Fractures in Men Study and followed them for an average of 4.6 years for changes in cognitive function.

Results: In a model adjusted for age, season, and site, men with lower 25(OH)D levels seemed to have a higher odds of cognitive impairment, but the test for trend did not reach significance (impairment by 3MS: odds ratio [OR] 1.84, 95% confidence interval [CI] 0.81-4.19 for quartile [Q] 1; 1.41, 0.61-3.28 for Q2; and 1.18, 0.50-2.81 for Q3, compared with Q4 [referent group; p trend = 0.12]; and impairment by Trails B: OR 1.66, 95% CI 0.98-2.82 for Q1; 0.96, 0.54-1.69 for Q2; and 1.30, 0.76-2.22 for Q3, compared with Q4 [p trend = 0.12]). Adjustment for age and education further attenuated the relationships. There was a trend for an independent association between lower 25(OH)D levels and odds of cognitive decline by 3MS performance (multivariable OR 1.41, 95% CI 0.89-2.23 for Q1; 1.28, 0.84-1.95 for Q2; and 1.06, 0.70-1.62 for Q3, compared with Q4 [p = 0.10]), but no association with cognitive decline by Trails B.

Conclusion: We found little evidence of independent associations between lower 25-hydroxyvitamin D level and baseline global and executive cognitive function or incident cognitive decline.

PubMed Disclaimer

Figures

None

Figure Road map of 1,606 participants with baseline 25(OH)D levels 25(OH)D = 25-hydroxyvitamin D; 3MS = Modified Mini-Mental State Examination; Trails B = Trail Making Test Part B.

Similar articles

Cited by

References

    1. Gloth FM III, Gundberg CM, Hollis BW, Haddad JG Jr, Tobin JD. Vitamin D deficiency in homebound elderly persons. JAMA 1995;274:1683–1686. - PubMed
    1. Goldray D, Mizrahi-Sasson E, Merdler C, et al. Vitamin D deficiency in elderly patients in a general hospital. J Am Geriatr Soc 1989;37:589–592. - PubMed
    1. Thomas MK, Lloyd-Jones DM, Thadhani RI, et al. Hypovitaminosis D in medical inpatients. N Engl J Med 1998;338:777–783. - PubMed
    1. Zadshir A, Tareen N, Pan D, Norris K, Martins D. The prevalence of hypovitaminosis D among US adults: data from the NHANES III. Ethn Dis 2005;15:S5–S101. - PubMed
    1. Holick MF. Vitamin D deficiency. N Engl J Med 2007;357:266–281. - PubMed

Publication types

MeSH terms

Substances

Grants and funding

LinkOut - more resources